Attached files

file filename
EX-10.1 - EX-10.1 - MYRIAD GENETICS INCd173578dex101.htm
EX-10.4 - EX-10.4 - MYRIAD GENETICS INCd173578dex104.htm
EX-31.2 - EX-31.2 - MYRIAD GENETICS INCd173578dex312.htm
EX-10.2 - EX-10.2 - MYRIAD GENETICS INCd173578dex102.htm
EX-10.3 - EX-10.3 - MYRIAD GENETICS INCd173578dex103.htm
10-Q - 10-Q - MYRIAD GENETICS INCd173578d10q.htm
EX-31.1 - EX-31.1 - MYRIAD GENETICS INCd173578dex311.htm

Exhibit 32.1

Certification

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

(Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code)

Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), each of the undersigned officers of Myriad Genetics, Inc., a Delaware corporation (the “Company”), does hereby certify, to such officer’s knowledge, that:

The Quarterly Report on Form 10-Q for the quarter ended March 31, 2016 (the “Form 10-Q”) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and the information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: May 4, 2016     Date: May 4, 2016
By:  

/s/ Mark C. Capone

    By:  

/s/ R. Bryan Riggsbee

Mark C. Capone     R. Bryan Riggsbee
President and Chief Executive Officer     Executive Vice President, Chief Financial Officer